Skip to main content
. 2021 May-Jun;47(3):e20200378. doi: 10.36416/1806-3756/e20200378

Table 4. Safety profile of adjuvant chemotherapy with cisplatin and vinorelbine in patients with non-small cell lung cancer after surgery.

Profile Present study ANITA triala
Grade 3-4 toxicity 89% N/A
Grade 5 toxicity 9% 2%
Grade 3-4 febrile neutropenia 29% 9%
Toxicity as reason for chemotherapy discontinuation 68% 34%
Hospitalization due to toxicity 49% N/A
a

Results based on Douillard et al. 4 ) ANITA: Adjuvant Navelbine International Trialist Association.